| 489718 |
NEURO-ONCOLOGY |
CSIG-17. SIGNALING PATHWAY-BASED CLUSTERING OF MASS CYTOMETRY DATA UNCOVERS CELLS ASSOCIATED WITH CLINICAL PROGRESSION IN GLIOBLASTOMA | CSIG-17. SIGNALING PATHWAY-BASED CLUSTERING OF MASS CYTOMETRY DATA UNCOVERS CELLS ASSOCIATED WITH CLINICAL PROGRESSION |
2019-11-01 |
10.1093/neuonc/noz175.187 |
Alvarado Alvaro, Alban Tyler, Nakano Ichiro, Lathia Justin, Goldman Steven, Kornblum Harley |
| 489717 |
NEURO-ONCOLOGY |
ACTR-69. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA | ACTR-69. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA |
2019-11-01 |
10.1093/neuonc/noz175.110 |
Barkhoudarian Garni, Blondin Nicholas, Chowdhary Sajeel, Fonkem Ekokobe, Vaillant Brian, Kesari Santosh |
| 489716 |
NEURO-ONCOLOGY |
NCOG-08. COGNITIVE DEFICITS AS A PREDICTOR OF THE COURSE OF TREATMENT IN DIFFUSE GLIOMA |
2019-11-01 |
10.1093/neuonc/noz175.669 |
IJpelaar Suzanne, Van Kessel Emma, Van Zandvoort Martine, De Vos Filip, Verhoeff Joost, Robe Pierre, Snijders Tom |
| 489715 |
NEURO-ONCOLOGY |
TMOD-01. CHARACTERIZATION OF PATIENT-DERIVED PRIMARY CELL LINES AND XENOGRAFTS FOR GLIOBLASTOMA | TMOD-01. CHARACTERIZATION OF PATIENT-DERIVED PRIMARY CELL LINES AND XENOGRAFTS FOR GLIOBLASTOMA |
2019-11-01 |
10.1093/neuonc/noz175.1100 |
Kijima Noriyuki, Kanematsu Daisuke, Shofuda Tomoko, Nonaka Masahiro, Iwata Ryoichi, Fukai Junya, Inoue Akihiro, Sasayama Takashi, Tsuyuguchi Naohiro, Kawashima Toshiyuki, Higuchi Yuichiro, Suemizu Hiroshi, Mori Kanji, Kishima Haruhiko, Kanemura Yonehiro |
| 489714 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Clinical outcomes of FFR negative intermediate coronary lesion in diabetic Vs non diabetic patients |
2019-11-01 |
10.1016/j.ihj.2019.11.034 |
Gomathinayagam V., Mullasari A.S., Kumar D.C., Vijayakumar S. |
| 489713 |
ONCOTARGETS AND THERAPY |
Long Non-Coding RNA STARD13-AS Suppresses Cell Proliferation And Metastasis In Colorectal Cancer |
2019-11-01 |
10.2147/ott.s217094 |
Yang Bin, Zhou Sheng-Ning, Tan Jia-Nan, Huang Jing, Chen Zhi-Tao, Zhong Guang-Yu, Han Fang-Hai |
| 489712 |
ONCOTARGETS AND THERAPY |
Unleashing The Potential Of Multiple-Targeted Therapies In Hepatobiliary Cancers: Two Cases, Cocktail Therapy With Nine Molecular Targeted Agents And Long-Lasting Survival |
2019-11-01 |
10.2147/ott.s223568 |
Lin Jianzhen, Yang Xiaobo, Xie Yuan, Zhao Haitao |
| 489711 |
NEURO-ONCOLOGY |
RARE-30. PEDIATRIC GLIOBLASTOMA IN THE POST-TEMOZOLOMIDE ERA: OUTCOMES AND CHARACTERISTICS |
2019-11-01 |
10.1093/neuonc/noz175.953 |
Chandra Ankush, Oh Taemin, Wadhwa Harsh, Shah Sumedh, Gupta Nalin, McDermott Mike, Berger Mitchel, Aghi Manish |
| 489710 |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease |
2019-11-01 |
10.3390/ijerph16214250 |
Parikh Aashka, Vinnard Christopher, Fahrenfeld Nicole, Davidow Amy L., Patrawalla Amee, Lardizabal Alfred, Gow Andrew, Panettieri Reynold, Gennaro Maria |
| 489709 |
NEURO-ONCOLOGY |
CBMT-28. FATTY ACID OXIDATION PROVIDES METABOLIC PLASTICITY TO MAINTAIN GROWTH IN THE DYNAMIC MICROENVIRONMENT OF GLIOBLASTOMA | CBMT-28. FATTY ACID OXIDATION PROVIDES METABOLIC PLASTICITY TO MAINTAIN GROWTH IN THE DYNAMIC MICROENVIRONMENT OF GLIOBLASTOMA |
2019-11-01 |
10.1093/neuonc/noz175.150 |
Kant Shiva, Kesarwani Pravin, Prabhu Antony, Graham Stewart, Buelow Katie, Nakano Ichiro, Chinnaiyan Prakash |
